Rifampicin, Antibiotic for Culture Media Use Only

CAS : 13292-46-1

Ref. 3D-R-6000

Informations sur le produit

• Nom: Rifampicin, Antibiotic for Culture Media Use Only
• Synonymes: 3-(4-Methylpiperazinyliminomethyl)rifamycin SV, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv., 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate, 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate, 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin, 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV, 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)-naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate, Abrifam, Ba 41166/E, Dipicin, Eremfat, Famcin, L 5103 Lepetit, Nih 10782, Nsc 113926, R-Cin, R/Amp, RIF, Refampicin, Rifa, Rifacap, Rifactine, Rifadin, Rifadin I.V., Rifadine, Rifaldazine, Rifaldin, Rifamate, Rifamicin AMP, Rifampicin SV, Rifampicina, Rifampicine, Rifampin, Rifamycin AMP, Rifamycin SV Sodium, Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-, Rifamyzin 3-(4-Methyl-Piperazinyl)Iminomethyl, Rifandin, Rifaprodin, Rifater, Rifobac, Rifodex, Rifoldin, Rifoldine, Riforal, Rimactan, Rimactane, Rimapen, Rimycin, Sinerdol, Tubocin

Description

Rifampicin is a drug that inhibits protein synthesis in bacteria and is used to treat tuberculosis. Rifampicin binds to the beta subunit of the bacterial RNA polymerase, inhibiting transcription and translation. It has been shown to inhibit the acetylcholine receptor function in rats, which may be related to its antituberculosis activity. Histopathological studies have shown that rifampicin inhibits the growth of human tumors in mice, including lung cancer, breast cancer, and leukemia. The drug is also being studied for its potential use in treating Alzheimer's disease. The pharmacokinetics and oral bioavailability of rifampicin have been studied and Rifampicin has been shown to be an effective anti-tuberculosis drug.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 822.94 g/mol
• Formule: C₄₃H₅₈N₄O₁₂
• Degré de pureté: Min. 90.0 Area-%